Journal of Clinical Trials
Open Access

Abstract

Erythroderma Due to the Association of Pegylated Interferon Alpha-2a and Ribavirin

Askour Majda, Bounniyt Hafsae, Jaiteh Lamin, Badrane Narjis, Senouci Karima and Hassam Badredine

The dermatological adverse effects due to the association of interferon Alpha and ribavirin in patients treated for hepatitis C are becoming more frequent but little is known about them. Such adverse effects range from eczema to the onset or the exacerbation of a pre-existing autoimmune disease. This may influence the therapeutic management of such patients.